Follow-up after primary therapy for endometrial cancer: a systematic review.
about
The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trialDetection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease.Breast and cervical cancer screening behaviours among colorectal cancer survivors in Nova ScotiaIsolated abdominal wall metastasis of endometrial carcinomaVaginal recurrence more than 17 years after hysterectomy and adjuvant treatment for uterine carcinoma with successful salvage brachytherapy: a case report.Salvage cytoreductive surgery for patients with recurrent endometrial cancer: a retrospective studySerum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies.Patterns and utility of routine surveillance in high grade endometrial cancerLong-term survival of endometrioid endometrial cancer patientsObstructing Colonic Mass: A Case of Recurrent Endometrial Cancer.What sampling device is the most appropriate for vaginal vault cytology in gynaecological cancer follow up?Increased NUCKS expression is a risk factor for poor prognosis and recurrence in endometrial cancer.Trends in Periodic Surveillance Testing for Early-Stage Uterine Cancer Survivors.Management of nodal recurrences of endometrial cancer with IMRTGynaecological cancer follow-up: national survey of current practice in the UK.The utility and management of vaginal cytology after treatment for endometrial cancer.Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.Fertility-preservation in endometrial cancer: is it safe? Review of the literature.Does intensity of surveillance affect survival after surgery for sarcomas? Results of a randomized noninferiority trial.Factors predicting recurrent endometrial cancer.The role of pathology in the management of patients with endometrial carcinoma.Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group.Detection of recurrence in early stage endometrial cancer - the role of symptoms and routine follow-up.Liver recurrence in endometrial cancer: a multi-institutional analysis of factors predictive of postrecurrence survival.Adrenal gland metastasis is an unusual manifestation of endometrial cancerSurvival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.Management of endometrial cancer.The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program.Diagnostic imaging using positron emission tomography for gynecological malignancy.A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway.Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.Cancer of the corpus uteri.Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma.ENdometrial cancer SURvivors' follow-up carE (ENSURE): Less is more? Evaluating patient satisfaction and cost-effectiveness of a reduced follow-up schedule: study protocol of a randomized controlled trial.Bioinformatic analysis of four miRNAs relevant to metastasis-regulated processes in endometrial carcinoma
P2860
Q33747342-D212B453-A3C6-4883-8860-1F0BEAF31F49Q33935290-038ACD31-3DA2-4C72-8B04-AF3BEFB747FCQ34305926-116EA272-47FC-4061-8800-A59B90A9CAE7Q34346912-1B53F48E-FBE2-47BE-BC80-232A93AAADF2Q34981530-63FA3251-B4A5-4B75-B1E5-686A86CB58CEQ35103319-FF536476-3E36-4C45-BD9B-0ECC3F5A01BAQ35128002-5F9EBF19-D539-4A53-8A43-701E4EBF34E9Q35609995-660F143F-BFFE-421B-ADAF-9A418D683CF7Q35793026-BFF9B297-0B1B-44A9-928E-18D22C60F8AFQ35827414-42C9B0BF-A083-4E15-A542-117224D5F9FDQ35829319-D26C6D7F-91E0-4D1A-ACB7-A1E7772B7A02Q36322382-9C075F2C-001B-40A4-A4BE-0E74D166D4B2Q36516602-6CAA9147-87E1-49F2-B18C-4ABC0CC05271Q36609765-D627B3C9-6D20-4D79-8CB6-B99347BE09BDQ37025688-8CF31669-42D4-4644-9DA3-D7F6403FA61DQ37065048-3230706C-B6D5-45DB-9112-715416F7AC9BQ37395946-997DADD2-5CBD-4F86-9E3D-AF7B3CC63F2EQ37553857-A98A7F21-C165-4720-9172-3348F92F6826Q37605349-9B4CDF1B-F736-4C78-9CA7-452972A31215Q37676587-8E146A1F-6AC0-4633-BB1E-89BDAF250047Q37703894-1B32C9FF-B4A4-4421-B9A5-4273D47BF6A6Q38686652-68DDE3FB-44F7-4F84-995E-FEF2D1F03C18Q38705372-A4F30DEE-7B53-465E-93E8-1612BF4FF55FQ38843266-A91AEDBF-737B-4410-9D35-AB4B4022B7E3Q39204658-A91DB62A-FE60-43F7-B71F-819D18E64059Q40383978-61C3553E-6B7E-457D-9F6E-F54B2B9B8436Q40684347-678A8BF3-982C-47DA-AB15-5CD4DD68AA9AQ42088780-E42F8C49-0969-45E7-80CA-E04B7C8ADD58Q44953646-C7110886-FB21-496F-9999-8576546AAB47Q46788590-EC3C337C-141E-405E-9273-AB7AD4789137Q47972647-3AF8EC19-EB05-48C9-BA0F-6D4A793D9688Q48105266-7459D0FE-CC41-4FC3-8D19-8DD786CACB5DQ48260907-D43F289E-9332-4E6A-B4D2-75CD6F8E17DAQ52680470-8C18264F-B1FD-4BA3-8951-09F1BE30F1ECQ53322874-989CB008-CA45-41A3-A235-7897D65134C9Q55282839-24948306-A6F6-4814-8642-CCCECF26F2AFQ55383688-F0291C27-89FF-4C56-80C7-CD04321E26C9Q58806319-90F0196C-CCFC-4342-B84E-6E26ACC222A8
P2860
Follow-up after primary therapy for endometrial cancer: a systematic review.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Follow-up after primary therapy for endometrial cancer: a systematic review.
@ast
Follow-up after primary therapy for endometrial cancer: a systematic review.
@en
type
label
Follow-up after primary therapy for endometrial cancer: a systematic review.
@ast
Follow-up after primary therapy for endometrial cancer: a systematic review.
@en
prefLabel
Follow-up after primary therapy for endometrial cancer: a systematic review.
@ast
Follow-up after primary therapy for endometrial cancer: a systematic review.
@en
P2093
P1433
P1476
Follow-up after primary therapy for endometrial cancer: a systematic review.
@en
P2093
Alex Chambers
Cancer Care Ontario Program in Evidence-based Care Gynecology Cancer Disease Site Group
Himu Lukka
Jason Dodge
Laurie Elit
Michael Fung-Kee-Fung
Tom Oliver
P304
P356
10.1016/J.YGYNO.2006.02.011
P407
P577
2006-03-23T00:00:00Z